The Swiss franc is widely viewed as a safe haven asset, rising in value in times of geopolitical or macroeconomic uncertainty ...

Roche (RHHBY) stock dips after 2025 results: sales, pharma & diagnostics growth, FX headwinds, and 2026 outlook.

The Swiss Franc is currently threatening to strengthen against the Euro, with potential implications for the SNB's policy.

Roche's key drugs lift sales by 7% at CER despite FX headwinds. The company expects mid-single digit sales growth in 2026.

The Swiss franc is cementing its position as the world’s go-to refuge after US President Donald Trump’s latest tariffs ...

The Euro to Swiss franc exchange rate (EUR/CHF) is trading at 0.9275, slightly higher on the day but still close to its lowest levels of the year after an extended January decline.

The dollar hit three-week lows against the euro and Swiss franc following White House threats concerning Greenland, ...

The AUD/CHF currency pair is drawing increased attention from technical traders, macro investors, and FX strategists alike. At the intersection of interest rate ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

Investing.com -- HBM Healthcare Investments (SIX: HBMN) on Friday reported a quarterly profit of CHF 191 million in the third quarter, bringing nine-month earnings to CHF 286 million despite currency ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

Safe haven assets are off to a good start in 2026, with widespread uncertainty sending gold and silver to new records and the ...